IBRAHIM T ALDOSS
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology DUARTE, CA NPI 1861692485
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology CA JAZZ PHARMACEUTICALS INC. All categories
General Payments — all program years on this page
$129,608.48
- Category: General Payments
- Program years: PY2018–2024
- Record count: 122
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $42,757.99 across 31 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $28,317.50 | 7 |
| Travel and Lodging | $10,183.04 | 2 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,080.00 | 1 |
| Food and Beverage | $1,177.45 | 21 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $21,536.81 | 13 |
| SERVIER PHARMACEUTICALS LLC | $7,650.00 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $5,521.92 | 2 |
| PFIZER INC. | $5,117.71 | 3 |
| Adaptive Biotechnologies Corporation | $2,545.75 | 3 |
| Kite Pharma, Inc. | $125.00 | 1 |
| Acerta Pharma LLC | $60.00 | 1 |
| Celgene Corporation | $50.16 | 2 |
| Amgen Inc. | $41.84 | 1 |
| Genentech USA, Inc. | $29.91 | 1 |
| Alexion Pharmaceuticals, Inc. | $29.24 | 1 |
| Genmab U.S., Inc. | $27.58 | 1 |
| Merck Sharp & Dohme Corporation | $22.07 | 1 |
By program year
Records — PY2024 (31)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.